Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
10.44
+0.16 (1.56%)
At close: Jun 27, 2025, 4:00 PM
10.04
-0.40 (-3.83%)
After-hours: Jun 27, 2025, 6:23 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $20.53 million as of June 27, 2025. Its market cap has increased by 173.18% in one year.
Market Cap
20.53M
Enterprise Value
13.16M
1-Year Change
173.18%
Ranking
Category
Stock Price
$10.44
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $20.53M, a decrease of -64.71%. That is a compound annual growth rate of -34.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 20.53M | -20.51% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 703.82B |
| Johnson & Johnson | 366.87B |
| AbbVie | 328.55B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 276.30B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 234.62B |
| AstraZeneca | 215.99B |